AstraZeneca Plc (LON: AZN) is a biopharmaceutical company engaged in the development and commercialisation of prescription medicines. It’s primary focus areas for the treatment of diseases include oncology, respiratory, inflammation & autoimmunity, neuroscience, cardiovascular, renal & metabolism, infection & vaccines. Presently, the group is a member of the FTSE 100 index of the London Stock Exchange.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK